Nvax stock price

Top Analyst Stocks Popular.

Key events shows relevant news articles on days with large price movements. Business Insider. Yahoo Finance. Novavax stock jumps after company settles dispute over canceled Covid vaccine purchase. The Motley Fool. PR Newswire. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Nvax stock price

Key events shows relevant news articles on days with large price movements. Palantir Technologies Inc. PLTR 9. Nikola Corp. NKLA 4. BNTX 0. Apple Inc. AAPL 0. Pfizer Inc. PFE 4.

Cash from investing. Novavax, Inc.

See all ideas. See all brokers. See all sparks. EN Get started. Market closed Market closed. No trades. NVAX chart.

Medical - Biomedical. Indices Russell Could these biotech companies still win in the vaccine market and beyond? The biotech company recently settled a dispute with a major customer. Without any windfalls on the horizon, times are dire for this biotech. Bull markets favor growth stocks so now could be the time for these players to shine.

Nvax stock price

Still, Novavax narrowed its losses in the quarter from the same period a year ago, even as demand for the biotech company's Covid vaccine — its only marketable product — and other shots and treatments that combat the virus continue to plummet worldwide. Here's what Novavax reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv:. But Jacobs also said on an earnings call with investors Wednesday that Novavax is "disappointed" with its performance in the U. Covid vaccine market last season. Several factors, such as the later entry of Novavax's updated Covid shot last fall, affected the company's ability to gain Covid vaccine market share in the U. But he said factors "outside of our control," including a smaller-than-expected Covid market size and an overwhelming number of vaccinations that took place in retail pharmacies, led Novavax to perform below expectations. Next season, Novavax also hopes to offer its vaccine in a pre-filled syringe, which would be more convenient than the shot's current five-dose vial form. Novavax reiterated its program to slash more expenses this year as part of the global cost-cutting plan it launched last year. The cuts will help Novavax focus on further developing its combination vaccine targeting Covid and the flu, which it plans to launch in The company expects to start a late-stage trial on that shot in the second half of the year.

Elle fanning naked

Top Research Firms. Net cash used or generated for core business activities. Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations. Today 0. Volume 9,, PFE 4. Novavax does not currently pay dividends. PR Newswire. The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks. Following the earnings report the stock price went down Alpha 0. Business Insider. Now it's time for the "wall of worry" as we head back up toward fib extensions.

Healthcare stocks , especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, treatment authorization, or any number of events that could be or break a company. It offers an authorized vaccine to treat Covid and a treatment for malaria.

Cash from financing. Purple one Follow 8, Followers. Stock brokers. The total amount of assets owned by a company. Viking Therapeutics Inc. Dividend yield. Underperform 1. Rating Consensus Hold. Sorry, No Data Available There is no website visitor data available for this stock.